MetaVia, Inc. is a clinical-stage biotechnology company, which engages in developing and commercializing multi-modal disease-modifying therapies. Its pipeline includes ANA001, a proprietary oral niclosamide formulation, Gemcabene, which is assessed as an acute indication for COVID-19, NB-01, a treatment for painful diabetic neuropathy, and NB-02, which has the potential to treat the symptoms of cognitive impairment and modify the progression of neurodegenerative diseases. The company was founded on October 30, 2014 and is headquartered in Cambridge, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
9
Frequently Asked Questions
What is Market Cap of MetaVia Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. MetaVia Inc. market cap is $24.92M.
What is the 52-week high for MetaVia Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. MetaVia Inc. 52 week high is $3.27 as of October 02, 2025.
What is the 52-week low for MetaVia Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. MetaVia Inc. 52 week low is $0.5555 as of October 02, 2025.
What is MetaVia Inc. stock price today?
MetaVia Inc. stock price today is $1.01.
What was MetaVia Inc. stock price yesterday?
MetaVia Inc. stock price yesterday was $1.03.
What is the PE ratio of MetaVia Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. MetaVia Inc.’s P/E ratio is -0.58.
What is the Price-to-Book ratio of MetaVia Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. MetaVia Inc. P/B ratio is 2.5894.
What is the 50-day moving average of MetaVia Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. MetaVia Inc. 50-day moving average is $0.7578.
